Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)

BACKGROUND: The aim of our analysis is to further characterise the prognostic relevance of early tumour shrinkage (TS) during VEGF-targeted therapy in mRCC, in order to explore whether this could define a group of patients with long-term survivorship. METHODS: A hundred patients were stratified into...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Seidel, C, Busch, J, Weikert, S, Steffens, S, Bokemeyer, C, Grünwald, V
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859945/
https://ncbi.nlm.nih.gov/pubmed/24169357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.662
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares